Rx Data Exclusivity Should Be Removed From Trade Deal, House Dems Say
This article was originally published in The Pink Sheet Daily
Executive Summary
The Dominican Republic-Central American Free Trade Agreement provision could prevent countries from gaining access to generic drugs during a public health emergency, lawmakers say. The language would grant drug manufacturers five years of protection on data needed to gain regulatory approval.